(Q43166289)

15 November 2017

Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

15 November 2017

0 references

1 reference

1 reference

Guanghui Li

1

1 reference

15 November 2017

Ling Fan

2

1 reference

15 November 2017

Li Zhang

3

1 reference

15 November 2017

Weiyuan Zhang

4

1 reference

15 November 2017

Xinghua Huang

5

1 reference

15 November 2017

language of work or name

1 reference

1 March 2010

1 reference

Journal of Perinatal Medicine

15 November 2017

1 reference

15 November 2017

38

1 reference

15 November 2017

2

1 reference

15 November 2017

141-146

1 reference

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

15 November 2017

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

What is gestational diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Pregnancy outcome in women with PCOS and in controls matched by age and weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Evaluation of the relationship between gestational diabetes and a history of polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Improving reproductive performance in overweight/obese women with effective weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Insulin-sensitizing agents in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Gestational Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Gestational Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPM.2010.034

21 January 2018

Identifiers

DOI

10.1515/JPM.2010.034

1 reference

15 November 2017

1 reference